Table 2 Medical therapy and procedures used in the two periods
Drugs | Pre-network N = 670 | Post-network N = 598 | P value |
|---|---|---|---|
Aspirin | 96.6% | 99.3% | 0.001 |
Clopidogrel | 54.3% | 79.9% | <0.001 |
Ticagrelor | ---- | 27.9% | ---- |
Prasugrel | ---- | 3.3% | ---- |
GP IIb/IIIa Inhibitors | 16.1% | 13.1% | 0.252 |
Heparin | 82.1% | 93.9% | <0.001 |
Betablockers | 69.3% | 81.2% | <0.001 |
Statins | 89.7% | 98.0% | <0.001 |
ACE inhibitors | 70.1% | 77.8% | 0.003 |
Nitroglicerin | 40.6% | 37.2% | 0.241 |
Eplerenone | ----- | 17.9% | ----- |
Mecanichal ventilation | 8.5% | 8.0% | 0.870 |
Echocardiogram | 40.3% | 56.0% | <0.001 |
Coronary angiography | 55.2% | 99.5% | <0.001 |
IABP | 4.8% | 4.1% | 0.680 |
Swan-Ganz cathether | 7.8% | 5.1% | 0.080 |
Reperfusion | 64.4% | 89.2% | <0.001 |
PPCI | 43.9% | 99.0% | <0.001 |
Thrombolysis | 56.1% | 1.0% | <0.001 |